[innovative Medicine] R&d, Senior Principal Scientist, Pharmacology Group, Preclinical Science &translational Safety Japan

Johnson & Johnson Johnson & Johnson · Pharma · Chiyoda, Tokyo, Japan

This role is for a Senior Principal Scientist in Pharmacology at Johnson & Johnson's Innovative Medicine division. The primary focus is on non-clinical submissions for regulatory approval in Japan, integrating data from toxicology, safety pharmacology, and DMPK. The scientist will prepare and review non-clinical sections of regulatory documents, collaborate with internal and external experts, and ensure compliance with Japanese regulatory requirements. While AI is mentioned as a modern approach to prepare documents, the core function is not AI/ML development but rather regulatory science and data integration in the pharmaceutical domain.

What you'd actually do

  1. Ensure appropriate studies are conducted at appropriate times to support drug development in Japan
  2. Ensure study results and their interpretation meet Japanese regulatory requirements.
  3. Ensure resolution to all project-related problems that might affect development in Japan.
  4. Ensure non-clinical submissions are of the highest scientific quality, and these are prepared within timelines by using modern approaches, including AI.

Skills

Required

  • Expert knowledge of the non-clinical area (strong background in biology, toxicology, pharmacology, DMPK)
  • Advanced knowledge of non-clinical notifications/guidance/guidelines in Japan/EU/US
  • Advanced knowledge of processes for IND/NDA
  • Advanced knowledge of other non-clinical areas
  • Intermediate knowledge of clinical areas
  • Experience in non-clinical areas for more than 15 years
  • Advanced presentation and negotiation skills with global mindset
  • Advanced communication skills in English
  • Advanced scientific skills in managing and developing the group members, including coaching, feedback and mentoring
  • Advance negotiation and influencing skills

Nice to have

  • Clinical Data Management
  • Drug Discovery Development
  • EHS Compliance
  • Emergency Planning
  • Performance Measurement
  • Presentation Design
  • Process Hazard Analysis (PHA)
  • Process Optimization
  • Program Management
  • Regulatory Affairs Management
  • Research and Development
  • Risk Management
  • Safety Audits
  • Safety Investigations
  • Safety-Oriented
  • Scientific Research
  • Strategic Thinking
  • Tactical Planning
  • Technical Credibility

What the JD emphasized

  • non-clinical submissions
  • regulatory submission documents
  • Japanese regulatory requirements
  • global health authorities
  • drug development in Japan
  • clinical studies and/or NDAs